These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 29486523)

  • 1. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
    Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
    Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin improves glucose homeostasis by enhancing glucagon-like peptide-1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice.
    Hui S; Huang L; Wang X; Zhu X; Zhou M; Chen M; Yi L; Mi M
    FASEB J; 2020 Jun; 34(6):8558-8573. PubMed ID: 32359008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
    Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
    Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
    Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling.
    Wang Q; Lin H; Shen C; Zhang M; Wang X; Yuan M; Yuan M; Jia S; Cao Z; Wu C; Chen B; Gao A; Bi Y; Ning G; Wang W; Wang J; Liu R
    Gut Microbes; 2023 Dec; 15(2):2274124. PubMed ID: 37942583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
    Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
    Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
    Potthoff MJ; Potts A; He T; Duarte JA; Taussig R; Mangelsdorf DJ; Kliewer SA; Burgess SC
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G371-80. PubMed ID: 23257920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
    Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
    Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
    Yan X; Li P; Tang Z; Feng B
    BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
    Burrin D; Stoll B; Moore D
    J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
    Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
    Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the mechanism of modified Gegen Qinlian decoction in regulating the intestinal flora-bile acid-TGR5 axis for the treatment of type 2 diabetes mellitus based on macro genome sequencing and targeted metabonomics integration.
    Liu R; Wang J; Zhao Y; Zhou Q; Yang X; Gao Y; Li Q; Bai M; Liu J; Liang Y; Zhu X
    Phytomedicine; 2024 Sep; 132():155329. PubMed ID: 38853123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
    Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
    Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
    Trabelsi MS; Daoudi M; Prawitt J; Ducastel S; Touche V; Sayin SI; Perino A; Brighton CA; Sebti Y; Kluza J; Briand O; Dehondt H; Vallez E; Dorchies E; Baud G; Spinelli V; Hennuyer N; Caron S; Bantubungi K; Caiazzo R; Reimann F; Marchetti P; Lefebvre P; Bäckhed F; Gribble FM; Schoonjans K; Pattou F; Tailleux A; Staels B; Lestavel S
    Nat Commun; 2015 Jul; 6():7629. PubMed ID: 26134028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.
    Baghdasaryan A; Claudel T; Gumhold J; Silbert D; Adorini L; Roda A; Vecchiotti S; Gonzalez FJ; Schoonjans K; Strazzabosco M; Fickert P; Trauner M
    Hepatology; 2011 Oct; 54(4):1303-12. PubMed ID: 22006858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.